Congress may move to lower drug prices later this year or next

Maybe – just maybe – Americans will get some relief from the relentlessly rising prices of pharmaceuticals.

That, of course depends on Congress pushing back against the drug companies’ formidable lobbying machine, their generous campaign contributions, and the industry’s historical coziness with members of Congress. But this year seems different.

When you consider that the country’s spending on pr...